Mousa O. Germoush
- Pharmacology top 1%
- Drug-Induced Hepatotoxicity and Protection 12
- Pharmacological Effects of Natural Compounds 3
- Biochemistry top 5%
-
- Nigella sativa pharmacological applications 5
-
- Chemotherapy-induced organ toxicity mitigation 9
- Molecular Medicine top 5%
-
- Synthesis and biological activity 6
-
- Biochemical effects in animals 4
-
- Aquatic Ecosystems and Phytoplankton Dynamics 3
-
- Computational Drug Discovery Methods 3
- Co-authors
- Ayman M. MahmoudOmnia E. HusseinMay Bin‐JumahMohammed AlotaibiMohammad H. AbukhalilHassan A. ElgebalyMohamed M. Abdel‐DaimMd. Habibur Rahman
- Partner nations
- Saudi ArabiaEgyptUnited Kingdom
In The Last Decade
Mousa O. Germoush
64 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 127
- Pharmacology 317
- Biochemistry 107
- Complementary and alternative medicine 142
- Pathology and Forensic Medicine 289
- Molecular Medicine 77
Countries citing papers authored by Mousa O. Germoush
This map shows the geographic impact of Mousa O. Germoush's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mousa O. Germoush with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mousa O. Germoush more than expected).
Fields of papers citing papers by Mousa O. Germoush
This network shows the impact of papers produced by Mousa O. Germoush. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mousa O. Germoush. The network helps show where Mousa O. Germoush may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mousa O. Germoush, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 5 | |
| 4 | 2025 | 3 | |
| 5 | 2024 | 0 | |
| 6 | 2024 | 4 | |
| 7 | 2024 | 1 | |
| 8 | 2024 | 2 | |
| 9 | 2024 | 12 | |
| 10 | 2023 | 1 | |
| 11 | 2022 | 13 | |
| 12 | 2022 | 12 | |
| 13 | 2021 | 115 | |
| 14 | 2020 | 33 | |
| 15 | 2019 | 122 | |
| 16 | 2018 | 73 | |
| 17 | 2017 | 20 | |
| 18 | Ruta graveolens Protects Against Isoniazid/Rifampicin-Induced Nephrotoxicity through Modulation of Oxidative Stress and Inflammation | 2016 | 9 |
| 19 | Antioxidant and anti-inflammatory effects of Padina pavonia and Turbenaria ornate in streptozotocin/ nicotinamide diabetic rats | 2016 | 3 |
| 20 | 2016 | 24 |
About Mousa O. Germoush
Mousa O. Germoush is a scholar working on Drug Discovery, Pharmacology and Complementary and alternative medicine, having authored 69 papers that have together received 1.7k indexed citations. Recurring topics across this work include Drug-Induced Hepatotoxicity and Protection (12 papers), Chemotherapy-induced organ toxicity mitigation (9 papers), Synthesis and biological activity (6 papers), Nigella sativa pharmacological applications (5 papers), Biochemical effects in animals (4 papers), Aquatic Ecosystems and Phytoplankton Dynamics (3 papers), Pharmacological Effects of Natural Compounds (3 papers) and Computational Drug Discovery Methods (3 papers). The work is most often cited by research in Pharmacology (317 citations), Biochemistry (107 citations) and Complementary and alternative medicine (142 citations). Mousa O. Germoush has collaborated with scholars based in Saudi Arabia, Egypt and United Kingdom. Frequent co-authors include Ayman M. Mahmoud, Omnia E. Hussein, May Bin‐Jumah, Mohammed Alotaibi, Mohammad H. Abukhalil, Hassan A. Elgebaly, Mohamed M. Abdel‐Daim, Md. Habibur Rahman, Amir M. Al Hroob and Osama Y. Althunibat. Their work appears in journals such as Scientific Reports, Molecules and Life Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.